dr. agarwal on the qol with apalutamide in metastatic castration-sensitive prostate cancer
Published 4 years ago • 116 plays • Length 1:46Download video MP4
Download video MP3
Similar videos
-
1:37
dr. agarwal on drug development in metastatic castration-sensitive prostate cancer
-
0:57
dr. agarwal on the tolerability of apalutamide in mcspc
-
1:26
dr. agarwal on potential agents for metastatic hormone-sensitive prostate cancer
-
2:13
dr. agarwal on the cosmic-021 trial design in castration-resistant prostate cancer
-
1:02
dr. agarwal on the safety profile of enzalutamide/talazoparib in mcrpc
-
1:37
dr. agarwal on the talapro-2 trial in mcrpc
-
8:33
titan phase 3 trial with apalutamide in metastatic castration sensitive prostate cancer
-
1:28
apalutamide plus adt leads to survival benefit in mcspc
-
5:48
data for metastatic castration-sensitive prostate cancer
-
1:17
dr. aggarwal on the future of adt for patients with prostate cancer
-
1:54
dr. agarwal on developing biomarkers of response to cabozantinib/atezolizumab in mcrpc
-
1:32
dr. agarwal on treatment for newly diagnosed prostate cancer
-
1:01
dr. agarwal on the advantages of docetaxel in prostate cancer
-
1:47
dr. saad on apalutamide combination for castration-resistant prostate cancer
-
2:22
dr. hwang on treatment selection in metastatic castration-sensitive prostate cancer
-
1:34
dr. chi on the titan trial results in metastatic castration-sensitive prostate cancer
-
1:30
dr. agarwal on the safety profile of olaparib in hrr gene-mutant mcrpc
-
1:23
dr. saad on the safety profile of apalutamide in m0crpc
-
1:44
dr. agarwal on the stampede and latitude trials for prostate cancer